共 161 条
[1]
Harris JR(1992)Medical progress: breast cancer N Engl J Med 327 7-1259
[2]
Lippman ME(1990)The clinical pharmacology of paclitaxel (taxol) Taxol – a novel investigational antimicrotubule agent. J Natl Cancer Inst 82 1247-25
[3]
Veronesi U(1993)Phase II trial of taxol, an active drug in the treatment of metastatic breast cancer Semin Oncol 20 16-1805
[4]
Willett W(1991)Paclitaxel (taxol) efficacy in patients with advanced breast cancer resistant to anthracyclines J Natl Cancer Inst 83 1797-33
[5]
Rowinsky EK(1994)Paclitaxel activity in heavily pre-treated breast cancer: a National Cancer Institute Treatment Referral Center trial Semin Oncol 21 29-2065
[6]
Cazenave LA(1995)Paclitaxel in doxorubicin-refractory or mitoxantrone-refractory breast cancer: a phase I/II trial of 96-hour infusion J Clin Oncol 13 2056-1629
[7]
Donehower RC(1994)Hypersensitivity reactions from taxol J Clin Oncol 12 1621-1268
[8]
Rowinsky EK(1990)European-Canadian randomized trial of paclitaxel in relapsed ovarian cancer: high dose versus low dose and long versus short infusion J Clin Oncol 8 1263-2666
[9]
Donehower RC(1994)Multicenter, randomized comparative study of two doses of paclitaxel in patients with metastatic breast cancer J Clin Oncol 12 2654-1867
[10]
Holmes FA(1996)Paclitaxel by 3 h infusion in combination with bolus Dox in women with untreated metastatic breast cancer: high antitumor efficacy and cardiac effects in a dose finding and sequence-finding study J Clin Oncol 14 1857-2699